Effect of Nitrous Oxide on Aggression.
Ohio State University · with National Institute of Mental Health (NIMH) · NCT06118567
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 21–55 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 2
- Target enrollment
- 50
- US sites recruiting
- 1
- Study start
- September 6, 2022
- Record last updated
- March 27, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this experimental medicine clinical trial is to test the hypothesis that nitrous oxide inhalation will result in a change in neurocircuit function in healthy controls and in individuals with impulsive aggressive tendencies. The main question aims to answer are: Does Nitrous Oxide normalize brain circuit function in impulsively aggressive individuals 24 hours after inhalation. Participants will undergo a 60 minute inhalation session with 50% Nitrous Oxide (or room air at another session) and then undergo an fMRI scan 24 hours later. Researchers will compare healthy controls and impulsively aggressive individuals to see if Nitrous Oxide can normalize the function of cortico-limbic circuits in the latter group.
Being studied: Nitrous oxide; Room Air
Conditions: Intermittent Explosive Disorder
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
All participants
- Between 21 and 55 years of age.
- Physically healthy (no clinically significant medical condition as confirmed by medical history/physical exam).
- Able to give informed consent.
Aggressive (IED) Study Participants (n = 25 Completed; 75 Enrolled).
- Current DSM-5 Criteria for IED
- LHA Aggression scores > 12
- Negative for a history of psychosis, bipolar disorder, developmental disorder, intellectual disability or a current substance use disorder.
Healthy, Non-Aggressive, Controls (n = 25 Completed, 75 Enrolled).
- Do not meet current/lifetime DSM-5 Criteria for any psychiatric disorder
- LHA aggression scores \< 12
Exclusion Criteria
- PCL Screening Version Score > 13; i.e., subject is likely to be psychopathic.32
- Current DSM-5 Major Depressive Episode.
- Life history of bipolar disorder/schizophrenia/organic mental syndrome.
- Intellectual disability [i.e., IQ \< 70].
- History of N2O abuse/dependence.
- Clinically significant medical condition.
- Current alcohol/drug use disorder of moderate or severe severity (i.e., subject is not in full remission from moderate to severe alcohol/drug use).
- Two weeks free of antipsychotic medication. (Note: Because a large number of individuals with aggressive tendencies in the community are already taking SSRIs, SNRIs, or mood stabilizers, these individuals will not be excluded if they continue to report impulsive aggressive behaviors at time of study.)
- Unwilling/unable to sign informed consent document.
Recruiting US locations
Ohio State University Wexner Medical Center
Columbus, OH 43210
Study contacts (from the official record)
- Jayla Copland, B.A. · 614-327-1707 · jayla.copland@osumc.edu
- Julian Roberts, R.N. · julian.roberts@osumc.edu
Similar studies in Ohio
All healthy volunteers studies in Ohio →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants
Hanmi Pharmaceutical Company Limited
- Location
- Cincinnati, OH
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
LH-001 vs Placebo in Healthy Participants
Chien-Liang Lin
- Location
- Columbus, OH
- Eligibility basics
- Ages 18–60
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Beachwood, OH + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1
A Study of V132 in Healthy Older Participants (V132-001)
Merck Sharp & Dohme LLC
- Location
- Columbus, OH + 9 other US sites
- Eligibility basics
- Ages 50–75